Влияние препарата Лозап на показатели основного обмена крыс с экспериментальным метаболическим синдромом

Abstract

We studied the effect of the preparation Lozap (angiotensin receptor antagonist) on the content of carbohydrates and lipids in the blood and liver of female rats with experimental metabolic syndrome. Under the action of the drug, atherogenic index and glucose level were decreased in the blood that was accompanied by increased deposition of glycogen and decreased content of phospholipids in the liver.